1. Home
  2. ILAG vs MYNZ Comparison

ILAG vs MYNZ Comparison

Compare ILAG & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILAG
  • MYNZ
  • Stock Information
  • Founded
  • ILAG N/A
  • MYNZ 2021
  • Country
  • ILAG Hong Kong
  • MYNZ Germany
  • Employees
  • ILAG N/A
  • MYNZ N/A
  • Industry
  • ILAG Office Equipment/Supplies/Services
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • ILAG Consumer Discretionary
  • MYNZ Health Care
  • Exchange
  • ILAG Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • ILAG 8.0M
  • MYNZ 9.8M
  • IPO Year
  • ILAG 2022
  • MYNZ 2021
  • Fundamental
  • Price
  • ILAG $0.68
  • MYNZ $0.41
  • Analyst Decision
  • ILAG
  • MYNZ Buy
  • Analyst Count
  • ILAG 0
  • MYNZ 2
  • Target Price
  • ILAG N/A
  • MYNZ $3.00
  • AVG Volume (30 Days)
  • ILAG 159.0K
  • MYNZ 1.3M
  • Earning Date
  • ILAG 07-30-2024
  • MYNZ 08-13-2024
  • Dividend Yield
  • ILAG N/A
  • MYNZ N/A
  • EPS Growth
  • ILAG N/A
  • MYNZ N/A
  • EPS
  • ILAG N/A
  • MYNZ N/A
  • Revenue
  • ILAG $6,443,357.00
  • MYNZ $895,479.00
  • Revenue This Year
  • ILAG N/A
  • MYNZ $67.40
  • Revenue Next Year
  • ILAG N/A
  • MYNZ $191.13
  • P/E Ratio
  • ILAG N/A
  • MYNZ N/A
  • Revenue Growth
  • ILAG N/A
  • MYNZ 69.00
  • 52 Week Low
  • ILAG $0.33
  • MYNZ $0.32
  • 52 Week High
  • ILAG $1.25
  • MYNZ $4.79
  • Technical
  • Relative Strength Index (RSI)
  • ILAG 71.17
  • MYNZ 43.42
  • Support Level
  • ILAG $0.49
  • MYNZ $0.39
  • Resistance Level
  • ILAG $0.58
  • MYNZ $0.46
  • Average True Range (ATR)
  • ILAG 0.05
  • MYNZ 0.08
  • MACD
  • ILAG 0.02
  • MYNZ 0.01
  • Stochastic Oscillator
  • ILAG 92.36
  • MYNZ 45.92

About ILAG Intelligent Living Application Group Inc.

Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Share on Social Networks: